Re: [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

Congrats Bill! Much-deserved.

 

Please keep inspiring all of us with your energy, commitment and accomplishments in substance use research!

 

 

Nehal P. Vadhan, PhD

Associate Professor

Director, Human Neuropsychopharmacology Laboratory (HNPPL)

Associate Director, Center for Addiction Services and Personalized Interventions Research (CASPIR)

Senior Research Scientist, Wellbridge Center for Addiction Science

Departments of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell

Feinstein Institute for Medical Research

E: nvadhan@northwell.edu  
P: 516-837-1685

 

https://feinstein.northwell.edu/institutes-researchers/our-researchers/nehal-p-vadhan-phd

https://www.northwell.edu/behavioral-health/programs-services/center-for-addiction-services-personalized-interventions-research

https://wellbridge.org/team/nehal-p-vadhan/

 

 

 

From: div28super reaches div28 and div28m and its nested lists (e.g. div28s) [mailto:DIV28SUPER@LISTS.APA.ORG] On Behalf Of Kelly Dunn
Sent: Thursday, February 25, 2021 4:00 PM
To: DIV28SUPER@LISTS.APA.ORG
Subject: [EXTERNAL] [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

 

External Email. Do not click links or open attachments unless you trust the sender and content. Report suspicious emails using Report Phishing button or forward email to phish@northwell.edu

Hello Div28 colleagues,

 

Please join me in congratulating Dr. Bill Stoops (CC'd here) for having recently been awarded an APA Presidential Citation. This is a rare and prestigious honor, but one that those of us who have been lucky enough to interact with Dr. Stoops know is fully warranted. The link to the citation and its website description is provided for you below. Note that your congratulation emails are welcomed, but please reply directly to Dr. Stoops rather than the extended listserv 🙂 

 

 

https://www.apa.org/about/governance/president/citation/william-stoops

 

William Stoops, PhD, was awarded a 2020 Presidential Citation for his brilliant research, multi-dimensional leadership at APA, and his positive, enthusiastic demeanor.

 

"Stoops is an extraordinary psychologist, a full professor of Behavioral Science, Psychiatry, and Psychology at the University of Kentucky (UK), and immersed in the professional and administrative workings of the University. Stoops oversees clinical research, engages with University leadership in strategic planning, and ensures compliance with budgeting in an array of centers of excellence on campus, including the UK Center for Clinical and Translational Sciences and the UK Clinical Research Support Office. Stoops' own research includes study in the neuropharmacology of various drugs of abuse and the development of internet-based treatments for substance abuse.

 

What is additionally impressive about Stoops, however, is his effective, enthusiastic leadership at APA. Stoops previously served on the Board of Convention Affairs (BCA), including serving as chair in 2017. He served as chair of the Council Effectiveness Work Group in 2020. Stoops currently serves on APA's Council of Editors and the Advocacy Coordinating Committee. At the same time, he is serving a second term on the Council of Representatives as representative for Div. 28, Psychopharmacology and Substance Abuse.

 

Stoops is always kind, inclusive, energetic, focused, rational. He is a superb listener as well as an accomplished leader who gets things done. We can rely on him to complete projects in a comprehensive, yet timely manner. For his brilliant research, multi-dimensional leadership, his positive, enthusiastic demeanor, I, Sandra L. Shullman, present this presidential citation to William Stoops."

 

 

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

 

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

Re: [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

Congrats, Bill! This is very impressive and well deserved.

 

From: "div28super reaches div28 and div28m and its nested lists (e.g. div28s)" <DIV28SUPER@LISTS.APA.ORG> on behalf of Kelly Dunn <kdunn9@JHMI.EDU>
Reply-To: Kelly Dunn <kdunn9@JHMI.EDU>
Date: Thursday, February 25, 2021 at 4:11 PM
To: "DIV28SUPER@LISTS.APA.ORG" <DIV28SUPER@LISTS.APA.ORG>
Subject: [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

 

Hello Div28 colleagues,

 

Please join me in congratulating Dr. Bill Stoops (CC'd here) for having recently been awarded an APA Presidential Citation. This is a rare and prestigious honor, but one that those of us who have been lucky enough to interact with Dr. Stoops know is fully warranted. The link to the citation and its website description is provided for you below. Note that your congratulation emails are welcomed, but please reply directly to Dr. Stoops rather than the extended listserv 🙂 

 

 

https://www.apa.org/about/governance/president/citation/william-stoops

 

William Stoops, PhD, was awarded a 2020 Presidential Citation for his brilliant research, multi-dimensional leadership at APA, and his positive, enthusiastic demeanor.

 

"Stoops is an extraordinary psychologist, a full professor of Behavioral Science, Psychiatry, and Psychology at the University of Kentucky (UK), and immersed in the professional and administrative workings of the University. Stoops oversees clinical research, engages with University leadership in strategic planning, and ensures compliance with budgeting in an array of centers of excellence on campus, including the UK Center for Clinical and Translational Sciences and the UK Clinical Research Support Office. Stoops' own research includes study in the neuropharmacology of various drugs of abuse and the development of internet-based treatments for substance abuse.

 

What is additionally impressive about Stoops, however, is his effective, enthusiastic leadership at APA. Stoops previously served on the Board of Convention Affairs (BCA), including serving as chair in 2017. He served as chair of the Council Effectiveness Work Group in 2020. Stoops currently serves on APA's Council of Editors and the Advocacy Coordinating Committee. At the same time, he is serving a second term on the Council of Representatives as representative for Div. 28, Psychopharmacology and Substance Abuse.

 

Stoops is always kind, inclusive, energetic, focused, rational. He is a superb listener as well as an accomplished leader who gets things done. We can rely on him to complete projects in a comprehensive, yet timely manner. For his brilliant research, multi-dimensional leadership, his positive, enthusiastic demeanor, I, Sandra L. Shullman, present this presidential citation to William Stoops."

 

 

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

 

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

 

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

Re: [#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

Congratulations Bill from one recent recipient of the award to another-

Clearly greatly deserved.

Martin

Be the light.

Sent from my iPhone

On Feb 25, 2021, at 1:12 PM, Kelly Dunn <kdunn9@jhmi.edu> wrote:



Hello Div28 colleagues,

Please join me in congratulating Dr. Bill Stoops (CC'd here) for having recently been awarded an APA Presidential Citation. This is a rare and prestigious honor, but one that those of us who have been lucky enough to interact with Dr. Stoops know is fully warranted. The link to the citation and its website description is provided for you below. Note that your congratulation emails are welcomed, but please reply directly to Dr. Stoops rather than the extended listserv 🙂 

https://www.apa.org/about/governance/president/citation/william-stoops

William Stoops, PhD, was awarded a 2020 Presidential Citation for his brilliant research, multi-dimensional leadership at APA, and his positive, enthusiastic demeanor.

"Stoops is an extraordinary psychologist, a full professor of Behavioral Science, Psychiatry, and Psychology at the University of Kentucky (UK), and immersed in the professional and administrative workings of the University. Stoops oversees clinical research, engages with University leadership in strategic planning, and ensures compliance with budgeting in an array of centers of excellence on campus, including the UK Center for Clinical and Translational Sciences and the UK Clinical Research Support Office. Stoops' own research includes study in the neuropharmacology of various drugs of abuse and the development of internet-based treatments for substance abuse.

What is additionally impressive about Stoops, however, is his effective, enthusiastic leadership at APA. Stoops previously served on the Board of Convention Affairs (BCA), including serving as chair in 2017. He served as chair of the Council Effectiveness Work Group in 2020. Stoops currently serves on APA's Council of Editors and the Advocacy Coordinating Committee. At the same time, he is serving a second term on the Council of Representatives as representative for Div. 28, Psychopharmacology and Substance Abuse.

Stoops is always kind, inclusive, energetic, focused, rational. He is a superb listener as well as an accomplished leader who gets things done. We can rely on him to complete projects in a comprehensive, yet timely manner. For his brilliant research, multi-dimensional leadership, his positive, enthusiastic demeanor, I, Sandra L. Shullman, present this presidential citation to William Stoops."

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] APA Presidential Citation Awarded to Div28 Member Dr. Bill Stoops

Hello Div28 colleagues,

Please join me in congratulating Dr. Bill Stoops (CC'd here) for having recently been awarded an APA Presidential Citation. This is a rare and prestigious honor, but one that those of us who have been lucky enough to interact with Dr. Stoops know is fully warranted. The link to the citation and its website description is provided for you below. Note that your congratulation emails are welcomed, but please reply directly to Dr. Stoops rather than the extended listserv 🙂 

https://www.apa.org/about/governance/president/citation/william-stoops

William Stoops, PhD, was awarded a 2020 Presidential Citation for his brilliant research, multi-dimensional leadership at APA, and his positive, enthusiastic demeanor.

"Stoops is an extraordinary psychologist, a full professor of Behavioral Science, Psychiatry, and Psychology at the University of Kentucky (UK), and immersed in the professional and administrative workings of the University. Stoops oversees clinical research, engages with University leadership in strategic planning, and ensures compliance with budgeting in an array of centers of excellence on campus, including the UK Center for Clinical and Translational Sciences and the UK Clinical Research Support Office. Stoops' own research includes study in the neuropharmacology of various drugs of abuse and the development of internet-based treatments for substance abuse.

What is additionally impressive about Stoops, however, is his effective, enthusiastic leadership at APA. Stoops previously served on the Board of Convention Affairs (BCA), including serving as chair in 2017. He served as chair of the Council Effectiveness Work Group in 2020. Stoops currently serves on APA's Council of Editors and the Advocacy Coordinating Committee. At the same time, he is serving a second term on the Council of Representatives as representative for Div. 28, Psychopharmacology and Substance Abuse.

Stoops is always kind, inclusive, energetic, focused, rational. He is a superb listener as well as an accomplished leader who gets things done. We can rely on him to complete projects in a comprehensive, yet timely manner. For his brilliant research, multi-dimensional leadership, his positive, enthusiastic demeanor, I, Sandra L. Shullman, present this presidential citation to William Stoops."

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

[#DIV28SUPER] Expanded Mentoring Program for RSA Meeting Attendees

Dear Colleagues and Students,

 

The RSA Education Committee and Mentoring Subcommittee is pleased to announce an expanded mentoring program for those planning to attend the meeting. It is ok to move forward with serving as a mentor and/or mentee before you have registered for the meeting.

 

The program has been expanded in 4 main ways:

 

1. Longer time period for mentoring pre-meeting (up to 3 months)
2. Expansion of who is eligible for mentoring (undergraduates through junior faculty and all levels in between) though preference will be given students, especially from underrepresented/disadvantaged backgrounds and first-time meeting attendees.
3. Expanded criteria upon which we will match including research interests/background, type of institution and aspects of lived experience.
4. Those at the graduate student through junior faculty levels may apply BOTH to serve as mentors and to receive mentorship. Those who would like to apply for both should complete both surveys below.

 

Below please find surveys to complete if you would like to serve as a mentor and/or request mentorship. If you have any questions, please do not hesitate to reach out to Mentoring Subcommittee Chair, Dr. Robert Leeman (Robert.leeman@ufl.edu, 352-294-1808).

 

*** We will begin matching mentors and mentees on Monday, March 8^th. After that date, we will continue to match on a rolling basis right up until the beginning of the meeting, but applying by the 8^th increases the chances of a match ***

 

 

Mentor: https://ufl.qualtrics.com/jfe/form/SV_6X4lKQsIzIdltps

 

Mentee: https://ufl.qualtrics.com/jfe/form/SV_4N3f4BzsWbvu3k2

 

 

Best,

 

The RSA Education Committee/Mentoring Subcommitee

 

[#DIV28SUPER] THE 2021 BOARD AND COMMITTEE CALL FOR NOMINATIONS IS NOW OPEN ONLINE!

Hello Colleagues,

Please see opportunities to become involved with APA Boards and Committees below.

Best

Kelly

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

---

 

This is a reminder that board and committee nominations are due March 1. 

 

The 2021 APA Board and Committee Call for Nominations form can be accessed here (https://nomination.apa.org/).  You will need to login using your MyAPA account ID and password.  If you haven't yet registered for your MyAPA account or have forgotten your login ID or password, simply follow the instructions provided once you click on the link.  March 1 is the deadline for submitting nominations.

 

Nominations are requested for the following boards and committees.

 

• Board for the Advancement of Psychology in the Public Interest
• Board of Educational Affairs
• Board of Professional Affairs
• Board of Scientific Affairs
• Committee on International Relations in Psychology
• Commission for the Recognition of Specialties and Subspecialties in Professional Psychology
• Committee on Rural Health
• Ethics Committee
• Finance Committee
• Membership Board
• Policy and Planning Board
• Publications and Communications Board

 

Please note that all APA meetings are being held in a virtual environment at least through June 30, 2021, primarily using a Zoom or other video platform.  Decisions regarding in-person meetings starting July 1, 2021, will be made at a later time.

 

If you have any questions, please contact the Election Office via email, or by phone at (202) 336-6087. All nominations must be submitted using the online form.

 

Additional Information:

 

• The Board of Directors encourages the nomination of those members who may be new to APA volunteer leadership or who are underrepresented in the current volunteer leadership structure.
• Self-nominations are encouraged.
• 2021 Calendar

• March 1 is the deadline for submitting nominations.
• The election slates are developed by respective boards and committees in the spring.
• The Board of Directors approves the slates at its June meeting.
• Following the June Board meeting, nominees are contacted to confirm their willingness to run, and serve, if elected, and to submit a statement to be included with the ballot.
• The Ballot is sent to members of the 2021 Council the last working day of October.

 

APA Election Office

 

Garnett Coad

Director, Elections, Governance Office

American Psychological Association

 

750 First Street NE, Washington DC  20002-4242

202-336-6087

800-374-2721

 

For your security, it is suggested that you do not send credit card or confidential information via email. You may fax to (202) 336-5502 or call the Service Center at 1-800-374-2721 with your information during our business hours 9am to 6pm Monday – Friday, Eastern Time.

 

 

LISTSERV INFO: The EARLYCAREER Listserv is an open non-confidential discussion group hosted by APA to discuss early career issues and to provide mutual support for people within the first ten years of graduation. Please be mindful of what you post and to whom you are replying. Requests for research participants are not allowed. Please read the complete listserv rules. To post to this list, use EARLYCAREER@lists.apa.org. To unsubscribe, send a blank message to EARLYCAREER-unsubscribe-request@lists.apa.org. To join other lists or contact staff, write to earlycareer@apa.org

[#DIV28SUPER] Fw: Opportunity to weigh in on NICCH and NINDS draft strategic plan

Hello Div28 colleagues,

The below message from APA provides an opportunity for you to offer feedback on NINDS and NCCIH's strategic plans.

Best

Kelly

 

__________________________

 

Dear APA Colleagues:

 

As you may be aware, several of the 27 institutes of the National Institutes of Health (NIH) are in the process of releasing their congressionally mandated 2021 -2026 strategic plans. Accordingly, these institutes are seeking feedback on those plans from the scientific community.

 

We hope you will take the opportunity to review the draft plans and respond to their requests for information. Their invitations for feedback allow psychologists an opportunity to ensure sufficient representation of behavioral and psychological science research in the various plans.

 

National Center for Complementary and Integrative Health

The National Center for Complementary and Integrative Health (NCCIH) is currently seeking feedback on its draft Strategic Plan for Fiscal Years 2021-2025, highlighting its research priorities and informing its funding decisions. The plan has five objectives:

 

1. Advance fundamental science and methods development
2. Advance research on whole-person health and integration of complementary and conventional care
3. Foster research on health promotion and restoration, resilience, disease prevention, and symptom management
4. Enhance the complementary and integrative health research workforce
5. Disseminate objective evidence-based information on complementary and integrative health interventions.

One of the final steps to the plan's release is to get feedback from the scientific community. NCCIH's strategic plan expands its "definition of integrative health to include whole-person health, or helping individuals improve their health in multiple interconnected domains: social, psychological, and physiological, including connections between organs and systems." It also emphasizes "strengthening [its] efforts toward integration of knowledge across disciplines, focusing on the whole person, taking a transdisciplinary approach that integrates the natural, social, and health sciences and transcends traditional boundaries." The plan also recognizes the need to support basic behavioral science.  We seek your assistance in determining whether these and the other references to behavioral and psychological science sufficiently capture the discipline's research. Are there noticeable gaps in the plan from your point of view? Please be sure to commend the institute for any elements in the strategic plan that can elevate psychological and behavioral science research.

 

The deadline to respond to NCCIH's Request for Information (RFI): Inviting Comments on the NCCIH Strategic Plan for Fiscal Years 2021-2025 (NOT-AT-21-005) is March 12, 2021. View the Draft NCCIH Strategic Plan FY 2021-2025, Submit a Comment on the Draft Plan. Please share your comments with the APA Advocacy staff (asharpe@apa.org).

The National Institute of Neurological Disorders and Stroke (NINDS)

The National Institute of Neurological Disorders and Stroke (NINDS) is also inviting public comment from its broad stakeholder community on its draft 2021-2026 NINDS Strategic Plan via a Request for Information on the 2021-2026 National Institute of Neurological Disorders and Stroke Strategic Plan (NOT-NS-21-021).

The NINDS plan addresses:

1. Science: Support and perform rigorous and important neuroscience research
2. Training and Workforce Diversity: Fund and conduct neuroscience research training and career development programs to ensure a vibrant, talented, and diverse neuroscience workforce.
3. Communications: Promote dynamic communication and diverse stakeholder engagement to accelerate scientific progress and reduce the burden of neurological disorders.
4. Communications: Promote dynamic communication and diverse stakeholder engagement to accelerate scientific progress and reduce the burden of neurological disorders.
5. Workforce Culture: Create and sustain a supportive work culture for the NINDS workforce that becomes the model for biomedical research and the neuroscience community.

We hope you will review NINDS' plan to ensure there are no glaring omissions of psychological and behavioral science research and the potential contributions of these sciences? Conversely, if there are areas where you think the institute should be commended for its foresight and leadership, we recommend you share those as well.

Submit any comments via NINDS' submission webform through March 15, 2021. We hope you will be willing to share any comments you make with the APA Advocacy staff (asharpe@apa.org).

For more information, please do not hesitate to contact me in Advocacy at asharpe@apa.org.

 

All the best,

Angela Sharpe

Angela L. Sharpe, MG
Senior Director, Congressional & Federal Relations

Scientific Affairs Advocacy
Email: asharpe@apa.org  | Tel: (202) 336-5688

American Psychological Association

Services, Inc.

750 First St. NE, Washington, D.C. 20002-4242

 

Twitter: @APA, @APAScience

 

 

 

Advancing psychology to benefit society and improve people's lives

 

All APA staff are teleworking until further notice and are experiencing a high volume of inquiries related to COVID-19. For immediate information and resources, visit APA's COVID-19 page for psychologists, health-care workers, and the public.

 

 

[#DIV28SUPER] Consider volunteering as a Division 28 Member-at-Large

Hello Division 28 members,

We will have an opening for member-at-large on the Division 28 Executive Committee for term 2022-2024.  Our ballot will need to be submitted soon and we can nominate 2 candidates. If you are a current Division 28 member who is interested in serving in this role, please send me a CV for consideration by Friday (2/19/21).

The job responsibilities will include participating in monthly phone calls and contributing to ongoing divisional efforts as desired. An expected time commitment per month would be 1-3 hours.

Warm regards,

Kelly

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

[#DIV28SUPER] Seeking volunteers to serve on PCORI's advisory panels

Hello colleagues,

ide  APA has asked Div28 leadership to forward the names of members who are who are interested in serving on the Patient-Centered Outcomes Research Institute's (PCORI) advisory panels. PCORI recently announced that it is seeking members for its five advisory panels.

1. Advisory Panel on Clinical Effectiveness and Decision Science
2. Advisory Panel on Healthcare Delivery and Disparities Research
3. Advisory Panel on Patient Engagement
4. Advisory Panel on Clinical Trials
5. Advisory Panel on Rare Disease

According to PCORI's authorizing legislation, its advisory panels must include representatives of practicing and research clinicians, patients, and experts in scientific and health services research, health services delivery, and evidence-based medicine who have experience in the relevant topic, and, as appropriate, experts in integrative health and primary prevention strategies.

Please email me (kdunn9@jhmi.edu) by March 4th if you are interested in having the Division forward your name for consideration to APA. 

Warm regards,

Kelly

---
Kelly Dunn, Ph.D., M.B.A.

President, Division on Psychopharmacology and Substance Use (Division 28)

American Psychological Association

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

[#DIV28SUPER] NIDA Neuroscience Update, February 10, 2021

Table of Contents:

I.                   I.  Enhancing Health Disparities Research Related to Substance Use and Addiction: Research Gaps and Opportunities

II.                 II. New Funding Opportunities

 

I.                   I. Enhancing Health Disparities Research Related to Substance Use and Addiction: Research Gaps and Opportunities

 

We invite you to attend the Enhancing Health Disparities Research Related to Substance Use and Addiction: Research Gaps and Opportunities Virtual Meeting.

When:

                February 16^th 1:00 pm to 5:00 pm EST

                February 17^th 1:00 pm to 5:00 pm EST

 

                Where: Zoom Webinar

                Please register here: https://seiservices.zoom.us/webinar/register/WN_phXk-hLdT9awpWTCGO9W9w

 

                Agenda

                Please see attached agenda for a full list of topics, questions to think about, speakers and panelists.

                Day 1: SOCIAL DETERMINANTS OF HEALTH

         Day 2: HARNESSING BASIC SCIENCE TO UNDERSTAND RACIAL DISPARITIES AND THE IMPACT OFRACISM

 

Workshop Description

The goals of this virtual meeting are to discuss research gaps on racial inequities in substance use and addiction and to inform NIDA’s commitment to this area by identifying short- and long-term plans for enhancing the research portfolio. Discussion will center on research in areas where there are known racial/ethnic inequities; and where research has the greatest potential to reduce those disparities. These include, but are not limited to, persistent health disparities related to substance use, addiction, and related outcomes; a lack of attention to research questions most salient to underrepresented communities; and existing system bias in the scientific enterprise. The overarching goal of the Research Gaps and Opportunities Workgroup is to engage the scientific community in identifying research priorities that can inform NIDA programs/funding opportunities and ultimately reduce health disparities and improve outcomes.

 

                Questions

                Please contact Caitlin Dudevoir at CDudevoir@leedmci.com

 

 

II.                 II. New Funding Opportunities:

 

·       High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed)
(RFA-DA-22-006)
National Institute on Drug Abuse
Application Receipt Date(s): September 15, 2021

 

·       Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
(RFA-DA-22-004)
National Institute on Drug Abuse
Application Receipt Date(s): July 14, 2021

 

 

·       NIH Blueprint for Neuroscience Research: Tools and Technologies to Explore Nervous System Biomolecular Condensates (R21 Clinical Trial Not Allowed)
(RFA-DA-22-008)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Sciences Research
Application Receipt Date(s): September 15, 2021

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L